Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Half Life Extended Factor Fviia Protein For Prevention And Treatment Of' Bleeding And Dosing Regimens Therefor
Abstract: The present invention relates to dosing regimens with half life extended Factor VIIa (FVIIa) for prophylactic and "on demand" treatment of bleeding as well as for preventing a bleeding episode during or after surgery in patients with congenital or acquired bleeding disorders. The present invention further relates to the use of half life extended FVIIa for treating or preventing blood loss in patients without bleeding disorders in situations of hemorrhage i.e. due to trauma or surgery. Another aspect of the invention is the treatment of acquired haemophilia.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
09 November 2016
Publication Number
06/2017
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application
Applicants
CSL Limited
45 Poplar Road, Parkville, Victoria 3052,
Australia
Inventors
1. BENSEN-KENNBDY, Debra
80 Horseshoe Point, Phoenixville,
Pennsylvania 19460, USA
2. VELDMAN Alex
Danziger Weg 11,61476
Kronberg/taunus, Cermany
3. ZOLLNER Sabine
Thunstrasse 70, CH-3074 Muri,
Switzerland
4. HBRZOG, Eva
Auf dem Heckenstück 14,35075
Gladenbach, Cermany
Specification
SOFT COPY ATTACHED IN PDF
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201647038251-FORM 3 [21-11-2017(online)].pdf | 2017-11-21 |
| 1 | Sequence List_As Filed_09-11-2016.pdf | 2016-11-09 |
| 2 | IB304_As Filed_09-11-2016.pdf | 2016-11-09 |
| 2 | Form 3 [21-04-2017(online)].pdf | 2017-04-21 |
| 3 | Form5_As Filed_09-11-2016.pdf | 2016-11-09 |
| 3 | Correspondence by Agent_Power of Attorney_15-11-2016.pdf | 2016-11-15 |
| 4 | Form3_As Filed_09-11-2016.pdf | 2016-11-09 |
| 4 | Assignment_As Filed_09-11-2016.pdf | 2016-11-09 |
| 5 | Form26_Power of Attorney_09-11-2016.pdf | 2016-11-09 |
| 5 | Claims_As Filed_09-11-2016.pdf | 2016-11-09 |
| 6 | Form2 Title Page_Complete_09-11-2016.pdf | 2016-11-09 |
| 6 | Correspondence by Agent_Form1_09-11-2016.pdf | 2016-11-09 |
| 7 | Form1_As Filed_09-11-2016.pdf | 2016-11-09 |
| 7 | Description Complete_As Filed_09-11-2016.pdf | 2016-11-09 |
| 8 | Drawing_As Filed_09-11-2016.pdf | 2016-11-09 |
| 9 | Form1_As Filed_09-11-2016.pdf | 2016-11-09 |
| 9 | Description Complete_As Filed_09-11-2016.pdf | 2016-11-09 |
| 10 | Correspondence by Agent_Form1_09-11-2016.pdf | 2016-11-09 |
| 10 | Form2 Title Page_Complete_09-11-2016.pdf | 2016-11-09 |
| 11 | Form26_Power of Attorney_09-11-2016.pdf | 2016-11-09 |
| 11 | Claims_As Filed_09-11-2016.pdf | 2016-11-09 |
| 12 | Form3_As Filed_09-11-2016.pdf | 2016-11-09 |
| 12 | Assignment_As Filed_09-11-2016.pdf | 2016-11-09 |
| 13 | Form5_As Filed_09-11-2016.pdf | 2016-11-09 |
| 13 | Correspondence by Agent_Power of Attorney_15-11-2016.pdf | 2016-11-15 |
| 14 | IB304_As Filed_09-11-2016.pdf | 2016-11-09 |
| 14 | Form 3 [21-04-2017(online)].pdf | 2017-04-21 |
| 15 | Sequence List_As Filed_09-11-2016.pdf | 2016-11-09 |
| 15 | 201647038251-FORM 3 [21-11-2017(online)].pdf | 2017-11-21 |